Technical Analysis for SNOA - Sonoma Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.7999 -0.01% 0.00
SNOA closed down 0.01 percent on Thursday, January 17, 2019, on 32 percent of normal volume.

Earnings due: Feb 6

1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical SNOA trend table...

Date Alert Name Type % Chg
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 17 Above Upper BB Strength 0.00%
Jan 17 Upper Bollinger Band Touch Strength 0.00%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.01%
Jan 16 Pocket Pivot Bullish Swing Setup -0.01%
Jan 16 Above Upper BB Strength -0.01%
Jan 16 Upper Bollinger Band Touch Strength -0.01%
Jan 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 8.09%
Jan 15 Upper Bollinger Band Touch Strength 8.09%
Jan 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.65%

Older signals for SNOA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
Is SNOA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 21 The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Dec 20 The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Dec 14 Sonoma Pharmaceuticals Announces Management Changes
Dec 12 What Kind Of Share Price Volatility Should You Expect For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA)?
Dec 7 The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut
Nov 21 Factors of Influence in 2018, Key Indicators and Opportunity within Sphere 3D, Solar Senior Capital, The Intergroup, Constellation Pharmaceuticals, Sonoma Pharmaceuticals, and OFS Capital — New Research Emphasizes Economic Growth
Nov 20 The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings
Nov 19 Mid-Afternoon Market Update: NASDAQ Down Over 3%; Spectrum Brands Shares Slide Following Downbeat Q4 Results
Nov 19 Microcaps dominate midday movers
Nov 19 Mid-Day Market Update: Dow Down Over 250 Points; Leju Shares Rise After Q3 Results
See more SNOA news...
Indicators
Indicator Value
52 Week High 5.5
52 Week Low 0.64
Average Volume 269,502
200-Day Moving Average 2.1515
50-Day Moving Average 0.8404
20-Day Moving Average 0.718
10-Day Moving Average 0.7431
Average True Range 0.0694
ADX 19.76
+DI 23.6068
-DI 10.7238
Chandelier Exit (Long, 3 ATRs ) 0.6318
Chandelier Exit (Short, 3 ATRs ) 0.8482
Upper Bollinger Band 0.7992
Lower Bollinger Band 0.6368
Percent B (%b) 1.0
BandWidth 22.618384
MACD Line -0.0178
MACD Signal Line -0.0399
MACD Histogram 0.0221
Fundamentals Value
Market Cap 3.44 Million
Num Shares 4.31 Million
EPS 1.96
Price-to-Earnings (P/E) Ratio 0.41
Price-to-Sales 1.34
Price-to-Book 1.01
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.90
Resistance 3 (R3) 0.91 0.87 0.89
Resistance 2 (R2) 0.87 0.85 0.87 0.88
Resistance 1 (R1) 0.84 0.83 0.82 0.83 0.88
Pivot Point 0.80 0.80 0.80 0.80 0.80
Support 1 (S1) 0.77 0.78 0.75 0.76 0.72
Support 2 (S2) 0.73 0.76 0.73 0.72
Support 3 (S3) 0.70 0.73 0.71
Support 4 (S4) 0.70